Excluder Conformable Aaa Endoprosthesis With Active Control
Payments companies reported to CMS as associated with Excluder Conformable Aaa Endoprosthesis With Active Control. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Excluder Conformable Aaa Endoprosthesis With Active Control, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Excluder Conformable Aaa Endoprosthesis With Active Control
These are the largest totals companies reported as associated with Excluder Conformable Aaa Endoprosthesis With Active Control. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Ross Milner | Chicago, IL | Vascular Surgery | $76,639.92 |
| Sukgu Han | Los Angeles, CA | Vascular Surgery | $47,634.37 |
| Robert Rhee | Brooklyn, NY | Vascular Surgery | $38,649.38 |
| Trissa Babrowski | Chicago, IL | Vascular Surgery | $38,098.21 |
| Jason Lee | Palo Alto, CA | Vascular Surgery | $37,649.72 |
| Nathan Liang | Pittsburgh, PA | Vascular Surgery | $29,059.95 |
| Gregory Magee | Los Angeles, CA | Vascular Surgery | $28,081.58 |
| Gustavo Oderich | Houston, TX | Vascular Surgery | $24,535.92 |
| Sharon Kiang | Los Angeles, CA | Vascular Surgery | $23,609.90 |
| Sara Zettervall | Seattle, WA | Vascular Surgery | $22,824.99 |
Prescribed Excluder Conformable Aaa Endoprosthesis With Active Control?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.